Results of a randomised trial assessing the effectiveness of different dosages of levofloxacin to cure Helicobacter pylori infection

, Tie-Li Peng, You-Ming Huang, , Lin-Li Zhao, Li-Ya Yao &
This dataset presents the results of a randomised clinical trial involving 400 participants, which aimed to compare the effectiveness, safety, and compliance of different dosages of levofloxacin used to cure Helicobacter pylori (H. pylori) infection.
Patients were assigned to either Group A or Group B, and received esomeprazole, amoxicillin, colloidal bismuth pectin and levofloxacin 500 mg once per day (group A); or levofloxacin 200 mg twice per day (group B) over a 14 day period.
This data repository is not currently reporting usage information. For information on how your repository can submit usage information, please see our documentation.